Department of Radiology

Publications

2017

Chen F, Ma K, Benezra M, Zhang L, Cheal SM, Phillips E, et al. Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations. Chem Mater. 2017;29(20):8766-8779.

Zhang W, Zhang Z, Tung C-. Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. Chem Commun (Camb). 2017;53(4):779-782.

Cheal SM, Fung EK, Patel M, Xu H, Guo H-, Zanzonico PB, et al. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer. J Nucl Med. 2017;58(11):1735-1742.

Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, et al. A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an [F]-Positron Emitting, Fluorescent Derivative of Dasatinib. Mol Cancer Ther. 2017;16(12):2902-2912.

Zhang W, Tung C-. Cisplatin Cross-Linked Multifunctional Nanodrugplexes for Combination Therapy. ACS Appl Mater Interfaces. 2017;9(10):8547-8555.

Kelly JM, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C, Vallabhajosula S, et al. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of Ga, In, Lu and Ac. Nucl Med Biol. 2017;55:38-46.

Zhang W, Tung C-. Sequence-Independent DNA Nanogel as a Potential Drug Carrier. Macromol Rapid Commun. 2017;38(20).

Lee HH, Bellat V, Law B. Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer. PLoS One. 2017;12(2):e0171044.

Thiele NA, Brown V, Kelly JM, Amor-Coarasa A, Jermilova U, MacMillan SN, et al. An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy. Angew Chem Int Ed Engl. 2017;56(46):14712-14717.

Pes L, Kim Y, Tung C-. Bidentate iminodiacetate modified dendrimer for bone imaging. Bioorg Med Chem Lett. 2017;27(5):1252-1255.